7RYTM : Analyst Expectations For Rhythm Pharmaceuticals&#...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $69.89, with a ...
Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan
Setmelanotide is a melanocortin-4 receptor (MC4R) agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic ...
Back in rhythm: Heart procedure helps Edinboro-area man feel his best 'in 3 or 4 years'
Up to 6 million Americans have been diagnosed with AFib and estimates are that as many as 12 million will have it by 2030.
New York Post26d
Daylight saving time is this week — 3 tips to ease into it so you don’t ruin your sleep
Try to embrace morning light in the days leading up to DST to maintain a healthy circadian rhythm. Dr. Alcibiades Rodriguez, director of sleep medicine at NYU Grossman School of Medicine ...
Medscape4d
Preventing Shoulder Pain After Cardiac Rhythm Management Device Implantation
Introduction: Shoulder pain and disability ipsilateral to the implant site is a common complication of cardiac rhythm device implantation, yet very little has been published about this morbidity.